Literature DB >> 21976705

TGFβ-activated kinase 1 (TAK1)-binding proteins (TAB) 2 and 3 negatively regulate autophagy.

Giichi Takaesu1, Takashi Kobayashi, Akihiko Yoshimura.   

Abstract

Transforming growth factor β-activated protein kinase 1 (TAK1)-binding protein 2 (TAB2) and its close homolog TAB3 are initially characterized as adapter proteins essential for TAK1 activation in response to interleukin-1β and tumour necrosis factor-α. However, the physiological roles of TAB2 and TAB3 are still not fully understood. Here we report that TAB2 and TAB3 bind to Beclin1 and colocalize in the cytoplasm. TAB2 also interacts with ATG13 and is phosphorylated by ULK1. Overexpression of TAB2 or TAB3 induces punctate localization of ATG5 under the normal culture condition. Knockdown of TAB2 and TAB3 results in the decrease in endogenous protein level of p62/SQSTM1 under the normal culture condition, while overexpression of TAB2 results in the accumulation of p62/SQSTM1 independently of TAK1. The decrease of p62/SQSTM1 induced by the knockdown of TAB2 and TAB3 is largely dependent on ATG5. These results suggest that TAB2 and TAB3 negatively regulate autophagy independently of TAK1 activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976705     DOI: 10.1093/jb/mvr123

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  20 in total

Review 1.  Precision autophagy directed by receptor regulators - emerging examples within the TRIM family.

Authors:  Tomonori Kimura; Michael Mandell; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

2.  TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.

Authors:  Sayaka Inokuchi-Shimizu; Eek Joong Park; Yoon Seok Roh; Ling Yang; Bi Zhang; Jingyi Song; Shuang Liang; Michael Pimienta; Koji Taniguchi; Xuefeng Wu; Kinji Asahina; William Lagakos; Mason R Mackey; Shizuo Akira; Mark H Ellisman; Dorothy D Sears; Jerrold M Olefsky; Michael Karin; David A Brenner; Ekihiro Seki
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition.

Authors:  Michael A Mandell; Ashish Jain; John Arko-Mensah; Santosh Chauhan; Tomonori Kimura; Christina Dinkins; Guido Silvestri; Jan Münch; Frank Kirchhoff; Anne Simonsen; Yongjie Wei; Beth Levine; Terje Johansen; Vojo Deretic
Journal:  Dev Cell       Date:  2014-08-07       Impact factor: 12.270

4.  TAK1 converts Sequestosome 1/p62 from an autophagy receptor to a signaling platform.

Authors:  Stephanie R Kehl; Brandy-Lee A Soos; Bhaskar Saha; Seong Won Choi; Anthony W Herren; Terje Johansen; Michael A Mandell
Journal:  EMBO Rep       Date:  2019-07-25       Impact factor: 8.807

5.  An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis.

Authors:  Tetsuya Takagawa; Atsushi Kitani; Ivan Fuss; Beth Levine; Steven R Brant; Inga Peter; Masaki Tajima; Shiro Nakamura; Warren Strober
Journal:  Sci Transl Med       Date:  2018-06-06       Impact factor: 17.956

6.  AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

Authors:  Jingyue Jia; Bhawana Bissa; Lukas Brecht; Lee Allers; Seong Won Choi; Yuexi Gu; Mark Zbinden; Mark R Burge; Graham Timmins; Kenneth Hallows; Christian Behrends; Vojo Deretic
Journal:  Mol Cell       Date:  2020-01-28       Impact factor: 17.970

7.  Inhibition of autophagy by TAB2 and TAB3.

Authors:  Alfredo Criollo; Mireia Niso-Santano; Shoaib Ahmad Malik; Mickael Michaud; Eugenia Morselli; Guillermo Mariño; Sylvie Lachkar; Alexander V Arkhipenko; Francis Harper; Gérard Pierron; Jean-Christophe Rain; Jun Ninomiya-Tsuji; José M Fuentes; Sergio Lavandero; Lorenzo Galluzzi; Maria Chiara Maiuri; Guido Kroemer
Journal:  EMBO J       Date:  2011-11-11       Impact factor: 11.598

8.  TRIM17 contributes to autophagy of midbodies while actively sparing other targets from degradation.

Authors:  Michael A Mandell; Ashish Jain; Suresh Kumar; Moriah J Castleman; Tahira Anwar; Eeva-Liisa Eskelinen; Terje Johansen; Rytis Prekeris; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-08-25       Impact factor: 5.285

Review 9.  Therapeutic targets for treating fibrotic kidney diseases.

Authors:  So-Young Lee; Sung I Kim; Mary E Choi
Journal:  Transl Res       Date:  2014-08-13       Impact factor: 7.012

Review 10.  Autophagy in infection, inflammation and immunity.

Authors:  Vojo Deretic; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Rev Immunol       Date:  2013-10       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.